These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15151139)
21. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years]. Quijada Fraile P; Martín Hernández E; Teresa García-Silva M Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125 [TBL] [Abstract][Full Text] [Related]
22. Huge Splenomegaly with Pancytopenia Due to Gaucher's Disease in a 22 Years Old Woman. Hasan MN; Rahman MA; Rahim MA; Ahmed MU; Islam MS; Rahman MR; Barua O Mymensingh Med J; 2019 Oct; 28(4):949-951. PubMed ID: 31599267 [TBL] [Abstract][Full Text] [Related]
23. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management. Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Weinreb NJ; Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Rosenbloom BE; Scott CR; Wappner RS; Zimran A Am J Med; 2002 Aug; 113(2):112-9. PubMed ID: 12133749 [TBL] [Abstract][Full Text] [Related]
29. [Gaucher disease--one of the possible causes of splenomegaly--case report]. Sokołowska B; Skomra D; Czartoryska B; Tomczak W; Tylki-Szymańska A; Repelewska M; Drop A; Gromek T Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093 [TBL] [Abstract][Full Text] [Related]
30. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience. MacKenzie JJ; Amato D; Clarke JT CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225 [TBL] [Abstract][Full Text] [Related]
31. Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases. Tsuboi K; Iida S; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Komatsu H; Banno S; Wakita A; Nitta M; Ueda R Int J Hematol; 2001 Apr; 73(3):356-62. PubMed ID: 11345203 [TBL] [Abstract][Full Text] [Related]
33. Imiglucerase treatment in Gaucher's disease. Shah U; Nadeem N; Husen Y; Fadoo Z J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722 [TBL] [Abstract][Full Text] [Related]
34. Rebound hepatosplenomegaly in type 1 Gaucher disease. Tóth J; Erdos M; Maródi L Eur J Haematol; 2003 Feb; 70(2):125-8. PubMed ID: 12581195 [TBL] [Abstract][Full Text] [Related]
35. [A 56-year-old patient with Gaucher's disease sustaining a pathologic subcapital fracture of the humerus]. Janke M; Börner M; Mueller-Garamvölgyi E; Hess R Orthopade; 2008 Mar; 37(3):251-2, 254-6. PubMed ID: 18251007 [TBL] [Abstract][Full Text] [Related]
36. A patient with type 2 Gaucher's disease with respiratory disease. Shebani E; Johannesson M; Strömberg B; Roomans GM J Pediatr; 2003 Feb; 142(2):209-10. PubMed ID: 12584549 [TBL] [Abstract][Full Text] [Related]
37. Gaucher disease: A cause of massive splenomegaly in a 15-year-old black African male. Ramdin T; Schapkaitz E; Varughese S; Sevitz H S Afr Med J; 2022 Feb; 112(1):13515. PubMed ID: 35139999 [TBL] [Abstract][Full Text] [Related]
38. Neurological features in Gaucher's disease during enzyme replacement therapy. Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058 [TBL] [Abstract][Full Text] [Related]
39. Resolution of a proximal humeral defect in type-1 Gaucher disease by enzyme replacement therapy. Pastores GM; Hermann G; Norton K; Desnick RJ Pediatr Radiol; 1995; 25(6):486-7. PubMed ID: 7491212 [TBL] [Abstract][Full Text] [Related]